Aristo Bio-Tech and Lifescience Limited IPO
Live Market Quote
Day 1 Exchange Open
Band: ₹72
Overall Bid Demand
Gross Public Offer
IPO Schedule & Key Dates
IPO Subscription Status
Breakdown of institutional, high-net-worth, and retail bidding demand
Listing Day & Return Performance
About Aristo Bio-Tech and Lifescience Limited IPO
Aristo Bio-Tech and Lifescience Limited is an Indian public offering categorized under the SME (Small and Medium Enterprise) segment. The public issue opened for bidding on 16 Jan 2023 and concluded on 19 Jan 2023, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹72.
During the bidding window, Aristo Bio-Tech and Lifescience Limited witnessed heavy demand with an overall subscription of 206.77 times. Institutional investors (QIB) subscribed —, non-institutional high-net-worth investors (NII) subscribed —, and retail individual investors (RII) bid — their reserved quota.
The equity shares of Aristo Bio-Tech and Lifescience Limited officially debuted on the stock exchanges on 30 Jan 2023 at an opening listing price of ₹80, delivering a listing day return of +11.11% (premium) over the final issue price. As per the latest market data, the stock trades at ₹89.15, representing an overall gain of +23.82% since its IPO allotment.